Fig. 2: Incidence of carbapenemase-producing Enterobacterales patients from 2010 to 2015.

The data is presented as (a) total incidence of patients resulting from putative clonal or plasmid-mediated transmission, or neither, b Incidence of patients among surveillance cultures only, c Incidence of patients among clinical cultures only, d Incidence of patients resulting from putative clonal transmission stratified by hospital or ward contact, e Incidence of patients resulting from putative plasmid-mediated transmission stratified by hospital or ward contact. Incidence is defined as the number of new patient pairs per 10,000 patient-days. Surveillance culture rate is defined as the number of surveillance cultures per 10,000 patient-days. Ward contact was further classified as direct or indirect, and in the absence of any form of ward contact, direct or indirect hospital contact. Time trends are presented as six-period (month) moving averages. Lines represent the incidence point estimate and the shaded areas represent the 95% CI of the estimate.